Masoondarou Bio-Pharmaceutical Company (MDPC) Founded in 2007, Masoon Darou Pharmaceutical Company (MDPC) is a knowledge-based biopharmaceutical company dedicated to the research, development, and manufacturing of innovative biological medicines, vaccines, and complex therapeutic products. The company integrates advanced scientific expertise with modern pharmaceutical technologies to develop high-value healthcare solutions that improve patient outcomes and address unmet medical needs. Today, MDPC operates with a multidisciplinary team of highly qualified scientists, researchers, pharmacists, and pharmaceutical engineers committed to scientific excellence, innovation, and continuous improvement. Through sustained investment in research and development, state-of-the-art manufacturing technologies, and rigorous quality systems, the company continues to expand its portfolio of advanced biopharmaceutical products. MDPC is the first manufacturer of following products in Iran and the region: • ZABOTRIX® – Monovalent and Polyvalent Botulinum Antitoxins • MASPORT® – Botulinum Toxin Type A • MAS-HibVAC® – Haemophilus Influenzae Type b (Hib) Conjugate Vaccine • MASTROPIN®- PMSG (Pregnant Mare Serum Gonadotropin) All products are manufactured in accordance with current Good Manufacturing Practice (cGMP) requirements under comprehensive pharmaceutical quality management systems, ensuring consistent product quality, safety, and efficacy in compliance with internationally recognized manufacturing standards. MDPC’s modern manufacturing facilities have been designed with production capacities significantly exceeding current domestic demand, enabling the company to reliably supply the national healthcare system while supporting strategic expansion into regional and international markets.